Shatavari Tafi Aiki Lokacin da Aka Hada da Ashwagandha a Mata 135
Shatavari tana daga cikin ganyen da Ayurveda ke ɗauka a matsayin muhimmin ƙarfafa lafiyar mata tun karni da yawa. Sabon gwaji mai rarrabewa da aka gudanar ya nuna cewa, idan aka haɗa da wani ganye, tasirin sa kan ƙara girma.
A cikin wani bincike na makonni takwas, du‑blind, wanda aka yi da placebo a kan mata 135, an ba da fitar da tushen shatavari da aka tantance. Wannan ya haɓaka aikin jima'i gaba ɗaya da gamsuwar jima'i. Lokacin da aka haɗa shatavari da fitar da tushen ashwagandha, an samu ƙarin haɓaka a ƙwarin gwiwa, sha'awa, cimma maniyi, yanayi da alamar farin ciki. Dukkan tasirin gefe sun kasance milmili. Amma babu rukunin ashwagandha kadai a cikin gwajin, don haka ƙirƙirar “haɗin gwiwa” na da mahimmanci.
Gwajin, wanda Ademola da abokan aikinsa suka jagoranta, an wallafa shi a cikin International Journal of Women’s Health a shekarar 2026 (DOI: 10.2147/IJWH.S561213; PubMed 41710148).
Menene Masana suka Gwada
Shatavari (Asparagus racemosus) an ɗauke ta a Ayurveda a matsayin Rasayana, wato ƙwayar da ke ƙarfafa jiki da kuma tallafa wa lafiyar haihuwa da jin daɗi na mata. Ashwagandha (Withania somnifera) kuma an san ta da zama adaptogen wanda ke taimakawa wajen rage damuwa.
Binciken an tsara shi ne a matsayin ƙwayar gaba, rarrabe, du‑blind kuma yana da rassan uku. Mahalarta sun karɓi ɗaya daga cikin waɗannan na tsawon makonni takwas:
- SHT: fitar da tushen shatavari da aka tantance
- SHT‑ARE: shatavari da ashwagandha (tushen ashwagandha da aka tantance)
- PL: placebo
Manufar farko ita ce Female Sexual Function Index (FSFI). Ma'aunin na biyu sun haɗa da yawan abubuwan da suka kawo gamsuwa a jima'i, damuwar jima'i (FSDS), yanayi (POMS), farin ciki (Oxford Happiness Questionnaire) da ingancin barci (PSQI). An kula da amincin ta hanyar bibiyar alamu na hanta, thyroid da kodan.
Sakamakon Da Ya Fito Da Karfi
Shatavari Kaɗai
Idan aka kwatanta da placebo, rukunin shatavari kaɗai ya nuna ci gaba a:
- Jimillar FSFI (P = 0.025)
- Sashen Gamsuwa (P < 0.0001)
- Damuwa ta Jima'i (FSDS) (P = 0.008)
Lura: sauran sassan FSFI ba su kai matakin muhimmanci ba a wannan rukuni.
Shatavari da Ashwagandha
Rukunin haɗin ya nuna faɗaɗɗen tasiri idan aka kwatanta da placebo:
- Jimillar FSFI (P = 0.005)
- Ƙwarin Gwiwa (P = 0.041)
- Sha'awa (P = 0.027)
- Maniyi (P = 0.031)
- Yawan Jima'i (P = 0.001)
- Damuwa ta Jima'i (FSDS) (P < 0.0001)
- Farin Ciki (OHQ) (P < 0.0001)
- Yanayi (POMS): raguwar damuwa, fushi, bacin rai, gajiya, ruɗani, da ƙarin jin daɗi (P < 0.0001)
Barci ya tsaya kusan a yadda yake ba tare da canji ba. Banbanci guda ɗaya a PSQI shi ne ingancin barci (P = 0.045) a rukunin haɗin.
Mawallafa sun ƙare da cewa shatavari amintacce ne, mai tasiri kuma ana iya ɗauka sauƙi, yayin da haɗin sa da ashwagandha ke ƙara tasiri.
Dalilin Da Ya Sa Haɗin Zai Iya Taimakawa
Aikin jima'i a mata ba ya takaita ga jiki kawai. Damuwa, rashin kuzari, gajiya da damuwar zuciya na shafar sha'awa da ƙwarin gwiwa. Rukunin haɗin ya inganta bangarorin jiki da na tunani a lokaci guda. Wannan ya dace da ra'ayin haɗa wani ƙarfin ganye da ake amfani da shi don mata da wani adaptogen da ke magance damuwa, ko da yake gwajin ba a tsara shi don tabbatar da wannan haɗin ba.
Wa Ya Dace Da Wannan Bincike
Dangane da takaitaccen bayani, hujjar ta shafi matan da ke sha'awar inganta aikin jima'i da jin daɗi, musamman waɗanda ke fama da damuwar jima'i ko ƙarancin gamsuwa. Takaitaccen ba ya fayyace ko an yi amfani da mata masu matsalar menopause ko wasu cututtuka. Ko sakamakon zai yi aiki ga mata da ke da yanayi na musamman, kamar alamomin menopause ko rashin ƙwanƙolin kwayoyin haihuwa, ba a bayyana ba.
Game da cikakken bayanin, takaitaccen ba ya nuna adadin, lokacin sha ko tsarin samfur. Idan kana sha'awar siyan kaya, duba takardar asali don ganin ainihin adadin. Nemi fitar da tushen da aka tantance, ba kawai garin gama gari ba, domin gwajin ya yi amfani da tantattun fitarwa. Ka ɗauki makonni takwas a matsayin lokacin da hujja ta nuna. Ba a bayar da bayanin abin da ke faruwa bayan wannan lokaci ba.
Amfanin Lafiya: Tabbas, Amma Da Sharhi
Dukkanin sakamakon illa da aka ba da rahoto sun kasance milmili kuma sun ƙare ba tare da wani magani ba. Masu binciken sun kuma bibiyi alamu na hanta, thyroid da kodan, matakin da ya nuna kulawa da aminci.
Sai dai, wannan gwaji ya ƙunshi mata 135 kacal. Ba zai iya kawar da tasirin da ke iya bayyana a gajeren lokaci ko na dogon lokaci ba. Ashwagandha an san ta da yiwuwar haifar da matsaloli ga thyroid da hanta a wasu ƙididdiga, kuma takaitaccen da ke ba da ƙarfi ba ya kawar da waɗannan damuwar. Mata masu ciki, masu shayarwa, masu amfani da maganin thyroid ko hormones, ko masu fama da cutar hanta ko cututtukan hormone su nemi shawarar likita kafin farawa. Waɗannan rukunin ba su bayyana a takaitaccen ba.
Muhimman Ka'idojin Da Ya Kamata a Sani
1. Ba a kwatanta ashwagandha kaɗai ba. Tsarin gwajin ya ƙunshi shatavari, shatavari da ashwagandha, da placebo. Rashin rukunin ashwagandha kadai na nufin ba za a iya tabbatar da tasirin sinergi ba; yana yiwuwa sakamakon haɗin ya kasance sakamakon ashwagandha kai tsaye.
2. Banbancin muhimmanci ba shi ne nasara kai tsaye. Haɗin ya samu muhimmanci a ƙarin sassa idan aka kwatanta da placebo, amma takaitaccen ba ya ba da kwatancen ƙididdiga tsakanin rukunin shatavari da haɗin. “Sauran akwatunan sun cika” ba ya nufin “an tabbatar da ya fi kowa”.
3. Yawan samfur, ƙananan rukuni. Gwajin ya ƙunshi mutane 135 kacal. Da ƙarin gwaje‑gwaje, wasu sakamako na iya zama sakamakon bazuwar, kuma na biyu ne mafi alamomi na inganci.
4. Sakamakon mutum‑kansa. Ma'aunin kamar FSFI da POMS an amince da su, amma na da rauni idan aka yi la’akari da tasirin tsammani, ko da a cikin tsarin du‑blind.
5. Halin gwajin kamfani. Amfani da fitar da tantattun kayayyaki da ƙirƙira waɗanda ke nuna alamar kamfani na iya nufin gwajin na tallafin kamfani. Takaitaccen ba ya bayyana wanene ya tallafa wa binciken. Duba takardun kuɗi da sanarwar rikicin sha’awa, sannan ka jira kwafin bincike mai zaman kansa kafin ɗaukar sakamako a matsayin karshe.
6. Kankanin tsawon lokaci. Makonni takwas ba su ba da tabbacin fa’ida ko amincin dogon lokaci ba.
Kammalawa
Wannan gwaji mai ƙirar “placebo‑controlled” yana ba da sakamako masu ƙarfi. Shatavari kadai ya inganta jimillar aikin jima'i, gamsuwa da rage damuwa, yayin da haɗin da ashwagandha ya ƙara faɗaɗɗen ci gaba a ƙwarin gwiwa, sha'awa, maniyi, yanayi da farin ciki. Sai dai, a gaba ya kamata a maimaita binciken tare da ƙara rukunin ashwagandha kadai, da bayyana cikakken bayanin kuɗi da haɗin gwiwa kafin a tabbatar da “haɗin” a matsayin gaskiya. A halin yanzu, alama ce mai ɗauke da daraja, ba umarni ba.
Source: Ademola et al., Int J Women’s Health, 2026. https://doi.org/10.2147/IJWH.S561213. Wannan labarin na bayanin kawai ne, ba shawara ta likita ba.
